Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
2023 Global: Biosimilar Contract Manufacturing - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
North America Human Insulin Drugs Market - By Product (Human Insulin, Basal Insulin, Bolus Insulin, Insulin Combinations, Biosimilar Insulins); By Application (Product I Diabetes, Product II Diabetes); By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Landscape & Forecast, 2019–2029 North America Human Insulin Drugs Market Size Grows Steadily to Touch USD 10.3 Billion by 2029 North America human insulin drugs market is flourishing because of an increasing prevalence of type ... Read More
-
Global Rituximab Biosimilars Market Report and Forecast 2023-2031
... of 15.7% during the forecast period of 2023-2031 to reach a value of USD 7.62 billion by 2031. The market growth can be attributed to the increasing prevalence of autoimmune diseases, cancer, and the rising ... Read More
-
Generic Drugs Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region and Competition
... Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region and Competition Generic Drugs Market was valued at ... Read More
-
Global Pegfilgrastim Biosimilars Market Report and Forecast 2023-2031
... of 7% during the forecast period of 2023-2031. The market growth can be attributed to the increasing prevalence of cancer, a growing geriatric population, and the rising demand for affordable cancer therapies. Global Pegfilgrastim Biosimilars ... Read More
-
Single Use Bioreactors Market by Product (System, Media Bag, Filtration assemblies), Type (Stirred tank, Bubble column), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines), End User (Pharma, Biotech, CROs, CMOs) & Region - Global Forecast to 2028
... as lower operational complexity of single-use bioreactors compared to conventional bioreactors, increasing adoption of single-use bioreactors among startups and SMEs, low water and energy consumption among others are expected to provide growth to the market. ... Read More
-
Global Innovative Biologics and Biosimilars Market Growth (Status and Outlook) 2023-2029
... expected to grow at a CAGR of % from 2023 to 2029. United States market for Innovative Biologics and Biosimilars is estimated to increase from US$ million in 2022 to US$ million by 2029, at ... Read More
-
Global Monoclonal Antibody Biologics and Biosimilars Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Monoclonal Antibody Biologics and Biosimilars is estimated to increase from US$ million in 2022 to US$ million ... Read More
-
Global Biosimilars Drug Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. United States market for Biosimilars Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Global Insulin Biologics and Biosimilars Market Growth (Status and Outlook) 2023-2029
... expected to grow at a CAGR of % from 2023 to 2029. United States market for Insulin Biologics and Biosimilars is estimated to increase from US$ million in 2022 to US$ million by 2029, at ... Read More
-
Global Rare Diseases Treatment Market Size study & Forecast, by Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic disorders, Endocrine disorders, Others) by Route of Administration (Oral, Injectable, Others), by Drug Type (Biologics, Biosimilar, Small Molecule), by Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029
... by Drug Type (Biologics, Biosimilar, Small Molecule), by Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029 Global Rare Diseases Treatment Market is valued at approximately USD 119.6 billion in 2021 and ... Read More
-
PEGylated Proteins Market by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia,
... User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028 Market Overview: The global PEGylated proteins market size reached US$ 1.16 Billion in 2022. Looking forward, IMARC Group expects the ... Read More
-
Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028. HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and ... Read More
-
Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 35,993 Million by 2028, exhibiting a growth rate (CAGR) of 20.41% during 2023-2028. The European biosimilar market represents the most mature in the world and continues to rally momentum. This market is expected to grow ... Read More
-
Global Interferon Alpha-2b Biosimilar Market Growth 2023-2029
... comprehensive analysis by region and market sector of projected Interferon Alpha-2b Biosimilar sales for 2023 through 2029. With Interferon Alpha-2b Biosimilar sales broken down by region, market sector and sub-sector, this report provides a detailed ... Read More
-
Global Interferon Biosimilar Market Growth 2023-2029
... region and market sector of projected Interferon Biosimilar sales for 2023 through 2029. With Interferon Biosimilar sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of ... Read More
-
Global Remicade Biosimilar Market Growth 2023-2029
... research report, the “Remicade Biosimilar Industry Forecast” looks at past sales and reviews total world Remicade Biosimilar sales in 2022, providing a comprehensive analysis by region and market sector of projected Remicade Biosimilar sales for ... Read More
-
US Public Health Spending on Biosimilars: a data driven analysis
... and patients. By the end of 2020, the FDA had approved 29 biosimilar products for eight different original biologic products. Of these, 18 had been launched by the end of that year with many more ... Read More
-
U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2023 - 2030
... & CRO Market Growth & Trends The U.S. biopharmaceutical CMO & CRO market size is expected to reach USD 16.7 billion by 2030, expanding at a CAGR of 6.1% during the forecast period, according to ... Read More
-
Biosimilars Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
... Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others) The biosimilars market was valued at US$ 18,435.89 million in 2021 and is expected to ... Read More
-
Global Biosimilar Testing Service Market Growth (Status and Outlook) 2023-2029
... options. Biosimilar have a unique properties, which is used to study the biological functions and structures complexity of the sample. LPI (LP Information)' newest research report, the “Biosimilar Testing Service Industry Forecast” looks at past ... Read More
-
Global Biosimilar Monoclonal Antibody Market Growth (Status and Outlook) 2023-2029
... clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic medical product ... Read More
-
Global Biosimilars & Follow-on-biologics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Biosimilars & Follow-on-biologics sales for 2023 through 2029. With Biosimilars & Follow-on-biologics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Global G-CSF Biosimilars Market Growth 2023-2029
... looks at past sales and reviews total world G-CSF Biosimilars sales in 2022, providing a comprehensive analysis by region and market sector of projected G-CSF Biosimilars sales for 2023 through 2029. With G-CSF Biosimilars sales ... Read More
-
Erythropoietin Drugs Market Size, Share & Trends Analysis Report By Type (Biologics, Biosimilars) By Product (Erythropoietin, Darbepoetin-alfa), By Application (Cancer, Renal Disease, Neurology), By Region, And Segment Forecasts, 2023 - 2030
... & Trends The global erythropoietin drugs market size is expected to reach USD 7.8 billion expanding at a CAGR of 1.5% from 2023 to 2030, according to a new report by Grand View Research, Inc., ... Read More
Research Assistance
